Laboratory Reference Grade Compounds

N-Acetyl Semax Amidate

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,250.00
Out of stock
Net Content10MG
InclusionVial Only
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose200 mcg – 400 mcg dailySyringe: 4.0 units (0.04 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
N-Acetyl Semax Amidate10MG · Vial Only
₱2,250.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: N-Acetyl Semax Amidate (NA-Semax-A) is an advanced modified version of Semax, featuring an N-terminal acetyl group and a C-terminal amide group.

How it works: These dual molecular modifications protect the peptide from degradation by aminopeptidases and carboxypeptidases in the bloodstream. This dramatically increases its biological half-life, enhances blood-brain barrier permeability, and delivers deeper, more sustained BDNF upregulation at lower micro-dose amounts compared to standard Semax.

Why researchers study it: Researched for extended cognitive focus, long-lasting mental stamina, neuroplasticity, memory retention, and combating mental fatigue with lower dosage requirements.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryCognitive & Neuroprotective
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number80714-61-0-AMIDATE
PubChem CID9811102↗
Molecular Weight855.96 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaAc-Met-Glu-His-Phe-Pro-Gly-Pro-NH2
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with Semaglutide

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

Cagrilintide (Amylin Analogue)

+99 Synergy
The CagriSema Protocol: Coordinated Amylin + GLP-1 Incretin Synergy

Cagrilintide engages area postrema and ventral tegmental amylin receptors while Semaglutide stimulates hypothalamic GLP-1 receptors, producing multiplicative appetite suppression and glycemic control superior to either monotherapy.

⏱Co-administered once weekly on the same day•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

BPC-157 (Pentadecapeptide)

+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

⏱Semaglutide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare
⚠️ Critical Safety Contraindication Warning:
Semaglutide is contraindicated to stack concurrently with Tirzepatide, Retatrutide. Both agents compete for the same receptor beds, risking severe adverse compounding without additive efficacy.